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ABSTRACT 
This studyinvestigatedthe relationship between Pbrelative bioavailability (RBA)and 
bioaccessibility, and their relationships with Pbin differentpools in 
soils.TwelvePb-contaminated soils representing different contamination sourcesfrom China 
were analyzed forPbbioaccessibilityusing four in vitromethods (UBM, SBRC, IVG, and 
PBET), Pb-RBAusing amouseblood model, and Pb fractionation using sequential extraction. 
Lead bioaccessibility in the gastric phase (GP) and Pb-RBA was generally lower in mining 
soils (0.4629%and 7.026%) than smelting (1992% and 3184%) and farming soils (1399% 
and 5161%), with more Pb in the residual fraction in mining soils. Lead bioaccessibilityvaried 
with assays, with SBRC (3.099%)producing significantly higher bioaccessible Pbthan other 
assays (0.4684%) in the gastric phase. However, Pb bioaccessibilityin the intestinal phase (IP) 
of all assays sharply decreased to 0.01–20%possibly due to Pbsorption to solid phase at higher 
pH. Lead bioaccessibility by UBM-GPassay was best correlated with Pb-RBA (r2=0.67), 
followed by IVG-GP (r2=0.55).Among different Pb fractions, strong correlation was found 
between Pb bioaccessibility/Pb-RBA andthe sum of exchangeable and carbonate fractions. Our 
study suggested thatUBM-GP assay has potential to determine Pbbioaccessibility in 
contaminated soils in China. 
Keywords: lead; contaminated soil; bioaccessibility; bioavailability; sequential extraction 
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1. Introduction 
Lead (Pb) exposure has been ofmajor public concern due to its well-established adverse 
neuro-behavioral effects on children[1, 2].After phasingoutof Pb from gasoline and paint, child 
blood Pblevelshave significantly declinedworldwide[3, 4].However, in Pb-contaminated sites 
such as mining andsmelting areas, childhood Pbpoisoning is still of concern[5, 6].Lead 
exposure to children near Pb-contaminated areas include incidental ingestion of soils via 
hand-to-mouth behaviors and inhalation of resuspended soil particles [7, 8]. Themean soil 
ingestion rate for children ranges from 1.2 to 23mg soil per day [9]. Therefore, assessment of Pb 
exposure through soil ingestion is receivingincreasing consideration [10]. However, risk 
assessmentsusually assume that allPb in soil isabsorbed into the blood systemic 
circulationfollowing oral ingestion (i.e., 100% bioavailable). In reality, Pb bioavailability in 
soil is often <100%, depending on soil properties and Pbspeciation[11].  
At present, several in vivo animal modelsincluding mouse and swine have beenused to 
assess Pbrelative bioavailability (RBA, relative to water soluble lead acetate)[11–14].However, 
in vivo assays are costly and time consuming, therefore not suitable to measure site-specific 
Pb-RBA on a large scale. As a result, various in vitro assays to determine Pb bioaccessibility 
have been developed, whichmeasures the soluble Pb fraction from soil in simulatedhuman 
gastrointestinalfluids[10–11, 15–16]. Commonmethods includeSolubility/Bioavailability 
Research Consortium method (SBRC), in vitro gastrointestinalmethod (IVG), physiologically 
based extraction test (PBET), DeutschesInstitutfürNormunge.V. method (DIN), and unified 
BARGE method(UBM) [17–21]. However, due to variation in gastrointestinal fluid 
components and assay parameters (e.g., pH, soil/solution ratio, and extraction time), different 
assays often producedifferentbioaccessibility results [10, 15, 22]. Therefore, before these 
assays can be used to accurately predict Pb-RBAin contaminated soils, they need to be 
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correlated toPb-RBA determined via animal models. 
To date, several studies have correlated Pb bioaccessibility in contaminated soils to 
Pb-RBAbased ondifferent models (swine, mouse, or rat) and methods (single versus multiple 
doses).For example,using 18 contaminated soils, Schroder et al.[17]showed a strong 
correlation(r2=0.79) between Pbbioaccessibilitybythe IVG gastric phase andPb-RBAbased on 
blood Pb following 15-dsoil dosing to juvenile swine.Strong correlations (r2=0.780.90, n=16) 
were observed betweenPbbioaccessibilityby UBM and Pb-RBA using a swine model and Pb in 
the kidney after 14-dsoil dosing[16]. Smith et al.[11]showed strong correlations(r2=0.78 and 
0.88, n=12) betweenPbbioaccessibility by SBRC andPb-RBA based on a mouse model and a 
single gavage dose.These studies demonstrated the predictive ability of a given assay for the 
tested soils. However,few studies have established in vivo–in vitrocorrelations (IVIVC) for 
different bioaccessibility assays using the same soils and investigatedthe variability of IVIVC 
within assays. 
Compared to limited in vivoPb-RBA studies, manystudies investigated Pbfractions in 
soils using sequential extraction [23, 24]. The methodofTessier et al. [25]is the most widely 
used, which operationally separatesPb into5 fractions, i.e., exchangeable Pb, and Pb associated 
with carbonates, Fe/Mn oxides, organic matter, and residualfractions, showing decreasing 
bioavailability. For example, Pb inthe carbonate and Fe/Mn oxides bound fractionsis more 
bioavailable than Pbinthe residual fraction [26, 27].However, correlations between Pb 
fractionation by sequential extraction and Pb bioaccessibilityare rarely established [23, 28]. 
For this study, we used a mouseblood model viaareas under the blood Pb concentration 
time curve (AUC) to measure Pb-RBA in soilswithPb acetate as a reference[11]. For 
bioaccessibility, we selected 4 common in vitro assays, including UBM, SBRC, IVG, and PBET. 
The overall objective of this study wasto investigate the relationship between Pb-RBAand 
Pbbioaccessibility and their relationships with Pbin differentfractions in contaminated 
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soils.This was accomplished by 1)correlatingPb-RBAin 12 Pb-contaminated soils via a 
mousebloodmodelwith Pbbioaccessibilityby four assays, and 2) correlatingPb bioaccessibility 
and Pb-RBA in soils with Pbin different fractions via sequential extraction.Establishing Pbin 
vivo–in vitro correlations using contaminated soils fromChina provides an extensionof the 
current knowledge of Pbbioaccessibility andPb-RBA done in other parts of the world. 
Correlations between Pb-RBAand Pbin differentfractions provide an insightof how Pbfrom 
differentpools contributes toPb-RBA.  
2. Materials and Methods 
2.1. Leadcontaminated soils 
Twelve soils from different contaminated sites in farmland and near mining and 
smelting areas were collected from China (Table 1). These sites represent Pb-contaminated 
sitesin China, including west-central Hunan, northwestern Henan, the junction of Yunnan, 
Guizhou, and Sichuan Provinces, central Guangxi Province, and the border between Shanxi and 
Gansu Provinces[29]. Due to its potential risk to human health, Pb contamination in these 
contaminated areas has received muchattentionrecently[30]. The farming soils were probably 
contaminated through application of fertilizers and pesticides as well as reused wastewater. The 
rest of soils were collected from typical mining/smelter sites in southern China. All soils were 
air-driedand sieved to<250μmfor bioavailability and bioaccessibility assessment. This fraction 
most likely adheres to children’s hands and is ingested via hand-to-mouth contact[31]. 
Soilsweredigested using USEPA Method 3050Band analyzed for totalPb 
concentrationsby inductively coupled plasma mass spectroscopy (ICP–MS, PerkinElmer 
NexION 300, USA). Total iron (Fe) concentrations were quantified using flame atomic 
absorption spectrometry (FAAS, PinAAcle 900T, PerkinElmer, USA).A certified soil reference 
material(D056)was included for quality assurance and quality control (QA/QC). The recovery 
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of Pb and Fe in D-056 was 95.0±1.56% and 101±5.96% (n=3).  
2.2. In vivo Pb bioavailability in soils 
Adult Balb/c mice with a body weight (bw) of 20–25gwere used. Animals were 
acclimatized in groups of 4, receiving a 12/12 light/dark photocycle at 20–22°C.Mice had free 
access to rodent diet obtained from Qinglongshan Experimental Animal Breeding Farm 
(Nanjing, China) and Milli-Q waterat all times. Mice werequarantined according to standard 
protocols at Nanjing University before starting the treatment. 
Preliminary tests of Pb acetate absorption pharmacokinetics in the micewere conducted 
(Fig. S1). A single dose (0.5 mL) of two Pb acetate solutions(250 and 500 mg L–1) 
wasadministered to fasted mice via gavage, which resulted in Pb dose levels of 5 and10 mg Pb 
kg–1 bw. The absorption kinetic curve was established by sacrificing 4 mice and collecting 
blood samples into heparin tubesat different time intervals (4, 8, 16, 24, and 48 h) after exposure. 
Blood samples were digested using USEPA Method 3050B and measured for Pb concentrations 
using ICP–MS. Areas under the blood Pb concentration time curve (AUC) were 4,284 and 
8,342 for the two doses of Pb acetate, indicating a linear dose-response in Pbconcentration 
rangeadministered,suggesting that Pb absorption was linearly dose-dependent. 
Similarly, toassessPb relative bioavailability (RBA) in soil, a single dose of soil 
suspensioncontaining 0.01–0.25 g of soil in 0.75 mL of Milli-Q water was administered to 
fasted mice via gavage, which resulted in soil Pb dose levels of 2.15–10.7 mg Pb kg–1 bw. The 
control group received only Milli-Q water. The time curve of mouse blood 
Pbconcentrationfollowing soil ingestion was established by sacrificing 4 mice at each time 
point (4, 8, 16, 24, and 48 h) after soil exposure and determiningPbconcentration in blood 
samples.Lead RBA was calculated using AUC withzero correction and dose normalization 
[11]: 
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oral soil oral Pb
oral Pb oral soil
AUC DRPb relative bioavailability (%) = 100                 (1)
AUC DR
 
  
   
whereAUCoralsoil and AUCoralPb= area under the blood Pb concentration time curve for 
Pb-contaminated soil and Pbacetate,and DRoralsoil and DRoralPb=Pbdose for Pb-contaminated 
soil and Pbacetate (mg Pbkg–1 mouse bw). 
2.3. In vitro Pbbioaccessibility in soils 
Fourin vitro methods(UBM, SBRC, IVG, and PBET),which have been widely used and 
correlated with in vivo data,were selected [11, 16–18].Their composition and analysis 
parameters are provided in Table S1. In short, 0.3 g of soilwasmixed withthe gastric phase (GP) 
solution in high density polyethylene tubes at soil:solution ratio of1:37.5 (UBM), 1:100 (PBET 
and SBRC), or 1:150 (IVG). The pH was adjusted to 1.2, 1.5, 1.8, and 2.5 for UBM, SBRC, 
IVG, and PBETusingconcentrated HCl. The mixtureswerehorizontallyshakenat 37°C and 
150rpm for 1h. The use of shaking rate at 150 rpm was to prevent soil particles sticking to the 
bottom of tubes and maximize the contact between sample and fluid.During GP extraction, 
solution pH was continuously monitored and adjusted usingconcentrated HCl. After GP 
extraction, the soil suspension was centrifuged at 4,000 rpm for 10 min and supernatant 
samples (1 mL for UBM, 3 mL for SBRC and PBET, and 4.5 mL for IVG) were pipetted and 
filtered (0.45μm), stored at 4°C before analysis of Pband Fe usingICP–MS and FAAS. 
Afterthe gastric phase,the solution was modified to simulate the intestinal phase (IP) by 
adjusting pH to 5.5 (IVG) and 7.0 (PBET) with NaHCO3, or 6.3 (UBM) and 7.0 (SBRC) with 
NaOH, and then adding bile and pancreatin(TableS1). The soil:solution ratio of UBM was 
increased to 1:97.5 in the intestinal phase. After 1h (IVG) or4 h (PBET, SBRC, and UBM) of 
extraction, thesoil slurry was centrifuged and supernatantsampleswere filtered 
(0.45μm),acidifiedby adding 200 μLconcentrated HNO3,and stored at 4°Cbefore analysis 
8 
 
usingICP–MS and FAAS.  
Leadbioaccessibilitywas calculated by dividing extractablePbin the gastric phase or 
intestinal phase of in vitro assays by total Pb in soil samples (<250 µm): 
extractable Pb Pb bioaccessibility (%) = 100           (2)
total Pb
In vitro   
   
For QA/QC, a standard soil reference material(NISTSRM 2711a, National Institute of 
Standards and Technology) was included. BioaccessiblePb based on the gastric phase of UBM, 
SBRC, IVG, and PBET assays were 926±5.11, 1,089±91.0, 1,069±36.5, and 610±22.0 mg kg–1, 
consistent with 1,044 mg kg–1(SBRC) [32] and 1,068, 1,066, and 554 mg kg–1(SBRC, IVG, and 
PBET) by Li et al. [33].  
2.4. Sequential extractionof soils 
Lead in the soils was fractionated according to Tessier et al. [25]. Lead fractions were 
operationally defined as follows: exchangeable, carbonate-bound, Fe/Mnoxides-bound, 
organic-bound, and residual fractions. Following each extraction, soil solutions were 
centrifuged at 10,000 rpm for10 min to retrieve the supernatant. The remaining soil residues 
were washed twice with Milli-Q water before continuing with the next step. After extraction of 
the organic-bound fraction, soil residues were digested using USEPA Method 3050B to 
determine Pb in the residual fraction. The supernatants and digested solutions were filtered 
(0.45μm), diluted with 0.1 M HNO3, and analyzed using ICP–MS.In the sequential extraction 
procedure, recoveriesof Pb (ratios of sum of five fractions to total Pb concentrations) in soil 
samples ranged from 75.0 to 118%, averaging 97.0±11.4%. 
2.5. Data processing and statistical analysis 
In vitro assaysand sequential extractions were performed in triplicate and animal 
experiments were with four replicates. The results were presented asmean values and standard 
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deviations.Differences in Pbbioaccessibilityamong in vitro methods were performed using 
variance analysis (ANOVA) based on Tukey's multiple comparisonsusingSAS version 9.1.3. 
Linear regression analysis between Pb bioaccessibility and Pb-RBAwasconducted using a 
repeated-median approach using R statistical analysis [16]. Simple linear correlations between 
Pb bioaccessibility/RBA and Pb in different fractions were established. All graphs were drawn 
using SigmaPlot 10.0. 
3. Results and discussion 
3.1. Characterization of Pbcontaminated soils 
The 12 Pb-contaminated soils were collected from different locations in China, 
representingPbcontamination from agricultural, smelting, and mining activities. The 
soilsvariedconsiderably in total Pb and Fe(Table 1). Lead concentrations in the soils varied by 2 
fold, rangingfrom 215to 25,329 mgkg–1.Soils 8 and 9 with the highest Pbconcentrations(9,958 
and 25,329 mgkg–1) werefrom asmelting area. Total Fe concentrations were 20.7–219 g kg–1, 
with the highestconcentration in soil 9. Soils 11 and 12 from mining areas also had high 
Pb(1,073 and 4,164 mg kg–1) and Fe concentrations (143 and 115 g kg–1).  
In addition to variation in total metals, the soils also varied in 
Pbconcentrationsindifferentfractions (Fig. 1). Lead in the firstfraction was 0.70–20.3% 
(exchangeable, E1), the second fraction 0.38–41% (carbonate, C2), the third fraction 0.02–55% 
(Fe/Mn oxides, F3), the fourth fraction 0.19–28% (organic, O4), and the fifth fraction 4.7–97% 
(residual, R5), averaging10, 22, 35, 13, and 20%, with F3>C2>R5>O4>E1.Similar 
Pbdistribution in contaminated soils was obtained by Jalali and 
Khanlari[34]withC2>R5>O4>F3>E1.In allsoilsexcluding 11, C2+F3 accounted for 4176%, 
indicating that Pbwasmainly associated withcarbonate and Fe/Mnoxide fractions. For soils 
from farming and smelting areas, 20–51%of the Pbwas in E1+C2 fraction, however, they 
accounted for much less(3.4–9.3%) in soilsfrom mining area. Soil 11 from mining 
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areacontained97% Pb in the residual fraction, suggesting low Pbbioavailability. Based on 
fractionation data, Pbbioavailabilitycouldvary greatly with soils.  
3.2. Pb bioaccessibility and relative bioavailability varied with soils 
Lead bioaccessibilityand Pb-RBA varied withthe soils. The range of Pb-RBA was 
narrower (7.084%, averaging 46%) than that of Pb bioaccessibility (0.4699%, averaging 
47%), but the means for the two were strickingly similar.Based on the gastric phase, 
Pbbioaccessibility was the highest in farming soils (1399%, averaging 64%), followed by 
smelting soils (1992%, averaging 57%) and mining soils (0.4629%, averaging 9.0%) (Fig. 2). 
Similar results were obtained by others with mining soils having the lowest Pbbioaccessibility 
[16, 18]. Likewise, Pb-RBAusing the mouse blood model varied with soils, with farming soils 
being the highest (5161%, averaging 57%), followed by smelting soils (3184%, averaging 
55%) and mining soils (7.026%, averaging 17%) (Table 1). ThesePb-RBA values fall within 
the Pb-RBArange of 1.0–108%that measured in Pb-contaminated soils from various sources 
(shooting range, mining, and smelting) [12, 17]. 
Lower Pb bioaccessibility and Pb-RBA have been reported for mining soils mainly due 
to the presence of insoluble Pb minerals (e.g., PbS) [18]. The differences in Pb bioaccessibility 
and Pb-RBA among soils can be explained by their different Pb fractionations in soils. Lead in 
the mining soils was primarily associated with less available forms including F3, O4, and R5 
(Fig. 1). Particularly, >90% of the Pb in soil 11 was in the residual fraction (R5). The lower Pb 
in the more bioavailable fractions (E1 and C2) in mining soils was consistent with their lower 
Pb bioaccessibility and Pb-RBAcompared to other soils. 
3.3. Pb bioaccessibility in the gastric phase 
Fig. 2 shows the variability in Pbbioaccessibility among 4 methods.Based on the gastric 
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phase, Pbbioaccessibilityin soils using UBM, SBRC, IVG, and PBET was 1.1–84, 3.0–99, 
0.46–71, and 0.85–60%, averaging44, 69, 46, and 28%with the order of SBRC>UBM= 
IVG>PBET. Generally, the highest Pbbioaccessibility was obtained by SBRC andthe lowest by 
PBET. Similar Pbbioaccessibilityin mining/smelting impacted soils was reported byDenys et al. 
[16] using UBM (9.2–83%),by Smith et al.[11] using SBRC (0.50–99%), by Schroder et al. 
[17]using IVG (0.05–37%), and by Ruby et al.[18]using PBET assay (3.80–41.0%).  
The disparity in Pbbioaccessibility between methods arises from the differences in 
assayparameters. As gastric pH strongly influencesPbsolubility in soils [18],lowergastric pH in 
SBRC (pH 1.5) than IVG and PBET (pH 1.8, and 2.5) partiallyattributed to 
thehigherPbbioaccessibilityby SBRC. However, pH couldnot explain the results for UBM, 
which has lower gastric pH value (pH 1.2)than SBRC, butlower Pbbioaccessibility. Differences 
in other assay parameters (e.g., soil:solution ratio) and gastric fluid components (e.g., chyme 
composition)were probably responsible. By comparing five in vitro methods, Van de Wiele et al. 
[15]reported that less Pb was dissolved under lower soil:solution ratio condition.  
Lowsoil:solution ratiomay underestimatePbbioaccessibilityin soils due to limited metal 
solubility [18]. Compared to SBRC (1:100), UBM usessoil:solution ratio at 1:37.5, which 
might inhibit Pb dissolution from soils,contributing to its lowerPbbioaccessibility.To test this 
hypothesis, we increasedsoil:solution ratio of UBM from 1:37.5 to1:100 and used soils2, 7, and 
12 for extractions, which represented farming, smelting and mining soils. For all 3 soils, 
Pbbioaccessibilityusing the modified UBM was increased from 65, 57, and 23% to 88, 82, and 
30%,averaging 18% increase(Fig. S2A). These resultssuggestedthat although UBM used a 
lower gastric pH, its ability to solubilizePb from soils was inhibited by its low soil:solution ratio, 
leading to lower Pbbioaccessibilitythan SBRC assay.  
In addition, different components used in gastric fluids of the 4 methods (pepsin and 
mucin for UBM, glycine for SBRC, and pepsin for IVG and PBET, Table S1) may have 
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contributed to the variability in Pbbioaccessibility among assays. To test this hypothesis, we 
used 10 g L–1of glycine, pepsin, and mucin solution at pH 1.5 toextract soil 8. Lead 
bioaccessibilityusing glycine (93%) was significantlyhigher than thatusing pepsin (72%) and 
mucin(77%) (Fig. S2B). The increased Pbbioaccessibility with glycine was probably related to 
its strong pH buffering ability [35]. We observed that more HCl (290 L) was needed to adjust 
20 mL of glycine solution to pH 1.5 than thoseneeded for adjusting pepsin and mucin solution 
(80 and 105 L) and Milli-Q water (70 L). Therefore, glycinein the gastric phase ofSBRC is 
another reason for itshighestPbbioaccessibilityamong the 4 assays, in addition to its low gastric 
pHand high soil:solution ratio. 
3.4. Pb bioaccessibility in the intestinal phase 
As pH increased from1.2–2.5 inthe gastric phase to 5.5–7.0 in the intestinal phase, 
solublePbin the gastric phase isprobably absorbed by soilsand Fe oxides [23, 36]. In the 
intestinal phase , average Pbbioaccessibilityin soils using UBM, SBRC, IVG, and 
PBETdecreased from 45 to 2.1%,69 to 9.3%, 46 to 6.0%, and 28 to 8.1%, i.e. by20, 7.4, 7.8, and 
3.5 fold, respectively (Fig. 2). Similar decrease in Pbbioaccessibilityby 2–45foldin the 
intestinal phase of SBRC and IVG has been observed in contaminated soils [17, 37]. 
Atneutral intestinal solutions, soluble Fe inthe gastric phase precipitates as Fe oxides, 
which adsorbssolublePb, decreasingPb solubility [11].In this study,for UBM, SBRC, and IVG, 
decreased Pb concentration in the intestinal phase was accompanied by a sharpdecrease in 
soluble Fe (Fig. S3A–C), suggestingprecipitation of soluble Fe as Fe oxides. Soluble Pb was 
probably absorbed onto Fe oxides and soils at elevated pH.However, for the PBET, decrease in 
Pbbioaccessibility was not always accompanied by decrease in soluble Fe. For example, 
soluble Fe in soils 4, 5, and 9 did not decrease from the gastric to intestinal phase (204–3,248 to 
209–3,029 mg kg–1), suggesting Fe was notprecipitated(Fig. S3D). This may beattributed to 
citrate in the UBM fluid, inhibiting Fe precipitation in the intestinal phase [33]. However, 
13 
 
Pbbioaccessibilityin the UBM-IP in the 3 soils still sharply decreased from 19–60to 3.1–9.0% 
(Fig. S3D). This wasattributed to Pbsorption onto soil matrix at pH 7 [11]. Li et al.[33] 
confirmed that Pb spiked inthe intestinal solutionsisabsorbed ontosolid matrix during intestinal 
phase extraction with house dust.  
3.5. Relationships between relative bioavailable Pb and bioaccessible Pb 
The linear in vivo–in vitrocorrelations (IVIVC) between Pbbioaccessibilityby the 4 
assays and Pb-RBA by a mouse model were established for the 12 soils using a 
repeated-median approach (Fig. 3). Compared to simple linear regression, this method 
considers the uncertainty of both Pb bioaccessibility and Pb-RBAmeasurements, providing a 
distribution of values (mean and 95% confidence interval) for regression descriptive 
statistics[16]. Summary of IVIVC statistics including r-square (r2), slope, and y-intercept and 
their 95% confidence intervals are shown in Fig. 4 and Table 2.  
The IVIVC varied with in vitro assays. In general, Pbbioaccessibilityinthe gastric 
phasewas better correlated with Pb-RBA than that in the intestinal phase, with r2 values of 0.67, 
0.43, 0.55, and 0.38 for UBM, SBRC, IVG, and PBET assays.TheUBM-GP provided 
satisfactorycorrelation with r2 >0.6as suggested by Wragg et al.[21]. In addition to r2, Wragg et 
al.[21] stated that IVIVC slope should be 0.8–1.2 and y-intercept not significantly different 
from 0. While the UBM-GP and PBET-GP met the slope criteria (0.80 and 0.87), SBRC and 
IVG did not (0.40 and 0.77). The y-intercepts for the gastric phase of UBM, SBRC, and IVG 
were similar at ~10, but PBET-GP was much higher at ~20. Considering all three parameters, 
we concluded that the UBM-GP provided the best correlation with Pb-RBA for the 12 soils. 
Poor IVIVC were found inthe intestinal phase of the 4 assays, with r2 of 0.01–0.24, primarily 
due to low soluble Pb. 
Previous studies have correlated Pbbioaccessibility by gastric phase of the 4 assays to 
Pb-RBA [11, 1618]. Compared to previous IVIVC (r2=0.78–0.93), correlations were weaker 
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(r2=0.38–0.67) in this study (Table 2).However, when IVIVC of UBM-GP and PBET-GP were 
compared to those by Denys et al. [16] and Ruby et al. [18] based on different animal models 
(swine and rat), there were no significant differences in slope and y-intercept (p=0.08–0.37). 
However, significant differences in slope(p<0.001) were observed when IVIVC of SBRC-GP 
and IVG-GP were compared to those of Drexler and Brattin[38]and Schroder et al.[17] using a 
swine blood Pb model. Smith et al. [11] established IVIVC for SBRC-GP in contaminated soils 
using mouse blood model. However, when compared to Smith et al.[11], significant difference 
was observed in slope (p=0.04). The different animal models and soil properties may have 
caused the different results. Our results confirmed the ability of UBM-GP to assess 
Pbbioaccessibility in contaminated soils from China. Future studiesare needed to investigate 
the impacts of selected animal models on Pb-RBA determination.  
3.6. Relationship between bioavailable Pb and sequentially extracted Pb 
Few studies have quantified the contributions ofPbin different fractionstobioaccessible 
and bioavailable Pb. Simple linear correlations between Pbbioaccessibility and Pb-RBA in 12 
soils and Pb in different fractions, including the first fraction E1, sum of the first and second 
fractions(E1+C2), the first three fractions (E1+C2+F3), and the first four fractions 
(E1+C2+F3+O4), were examined (Table 3). In general, Pbbioaccessibility in the gastric 
phasewasmore strongly correlated with Pb fractionation data than that in the intestinal phase. 
Among different fractions, satisfactory correlation of r2>0.6 was found between 
Pbbioaccessibilityinthe gastric phase and Pb in E1+C2 (r2=0.68–0.87) and 
E1+C2+F3(r2=0.65–0.76). These results suggested that variation in Pbbioaccessibility among 
soils could be best explained by Pb pools in E1+C2, followed by E1+C2+F3.  
Here, we used the benchmark for IVIVC to assess the correlation. When relationships 
between Pb in E1+C2 and Pbbioaccessibilityby the gastric phasewere examined, 
y-interceptswere close to 0 (–1.99 to 10.3) (Table 3). Among 4 assays, Pb in E1+C2 was best 
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correlated with Pbbioaccessibility by SBRC-GP (r2=0.87) with a slope of 1.87, indicating Pbin 
E1+C2 was lower thanbioaccessible Pb measured by SBRC-GP.When relationships 
wereexaminedfor UBM, IVG, and PBET,slopes became lower to 0.94–1.28. Considering all 
three parameters (r2, slope, and y-intercept), we concluded that bioaccessible Pb inthe gastric 
phaseof all 4 assays could bepredicted using Pb inE1+C2, though E1+C2 
underestimatedbioaccessible Pb by SBRC-GP. When Pb in E1+C2+F3 was correlated to 
bioaccessible Pb by SBRC-GP (r2=0.75), the slope decreased to 1.29, suggesting that 
bioaccessible Pb by SBRC-GP was better reflected by Pb in the first 3 fractions.  
Similar to bioaccessible Pb, Pb-RBAwas better correlated with Pb pools in E1+C2 
(r2=0.52) than Pbin E1, E1+C2+F3, and E1+C2+F3+O4 (r2=0.32–0.42) (Table 3). This 
suggested that bioavailablePb also mainly came from Pb in the exchangeableand carbonate 
fractions.  
4.Conclusion 
Results from this study suggestedthatPb bioaccessibility and Pb bioavailability in 
contaminated soils depended on soil types and methods used, supporting the hypothesis that 
site-specific approach is necessary to accurately determine Pb bioavailability.The UBM gastric 
phaseassay was the best among the fourin vitro assays tested to predict Pb-RBAin 12 
contaminated soils fromChina, though other assays also showed predictive ability.Hence, in 
vitroassays can beuseful in risk assessment of contaminated soils. To reduce human health risk 
associated with oral ingestion of contaminated soil, remediation measures are neededto reduce 
exchangeable and carbonate associatedPb fractions,which contributed the most to bioaccessible 
and bioavailable Pb in Pb-contaminated soils.  
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Table1. Selected properties and Pb relative bioavailability (RBA) of 12 contaminated soils 
from China 
Sample 
 
Contamination 
Source 
Location Total Pb 
(mg kg1) 
Total Fe 
(g kg1) 
RBA 
(%) 
1 Farming Huangshi, Hubei 215±0.62 28.8±0.84 51.4±16.2 
2 Jiyuan, Henan 734±4.24 30.4±0.33 59.7±19.8 
3 Jiyuan, Henan 1,306±19.4 26.5±0.58 55.8±16.5 
4 Jiyuan, Henan 1,543±16.0 27.9±0.48 60.5±20.1 
5 Smelting Fengxian, Shanxi 250±4.19 30.7± 0.58 56.9±18.7 
6 Fenglan, Gansu 515±11.0 37.5±0.29 84.3±12.1 
7 Shuikou, Hunan 1,174±12.6 22.7±0.55 62.3±25.3 
8 Zhuzhou, Hunan 9,958±243 41.0± 0.53 39.6±5.28 
9 Zhuzhou, Hunan 25,329±213 219±2.00 30.8±9.39 
10 Mining Hechi, Guangxi 516±7.03 20.7±0.19 7.00±1.80 
11 Shimen, Hunan 1,073±4.89 143±1.31 16.4±8.48 
12 Gejiu, Yunnan 4,164±77.6 115±5.11 26.0±5.35 
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Table 2.Comparison of in vivo–in vitrocorrelations (IVIVC) betweenPb relative bioavailabilityand Pb bioaccessibility for gastric (GP) and 
intestinal phases (IP) of UBM, SBRC, IVG, and PBET assaysin the currentstudy and previous studies in contaminated soils 
In vitro 
assay 
 
Phase 
IVIVC parameters Pb 
concentration 
(mg/kg) 
No. of 
soil 
samples 
In vivo assay  
Reference slope y-intercept r2 animal  biomarker method 
This study 
UBM GP 0.80 9.99 0.67 214–25,329 12 mouse blood AUC This study 
IP 1.26 47.8 0.01 
SBRC GP 0.40 14.0 0.43 
IP 2.54 26.3 0.21 
IVG GP 0.77 6.36 0.55 
IP 4.17 22.7 0.24 
PBET GP 0.87 18.9 0.38 
IP 2.38 29.6 0.20 
Previous studies 
UBM GP 1.07 –6.25 0.88 1,630–40,214 16 swine kidney DRC [16] 
SBRC GP 0.88 –0.03 0.92 1,270–14,200 19 swine blood DRC [38] 
GP 0.94 –21.7 0.78 576–2,248 12 mouse blood AUC [11] 
IVG GP 1.53 2.22 0.79 1,270–14,200 11 swine blood DRC [17] 
PBET GP 1.41 3.19 0.93 1,388–10,230 7 rat blood  [18] 
AUC: area under blood Pb time curve; DRC: dose response curve. 
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Table 3.Linear correlations between Pbbioaccessibilitydetermined usingthe gastric (GP) and intestinal phases (IP) of four assays (UBM, 
SBRC, IVG, and PBET) and Pbin different fractionsand between Pb relative bioavailability (RBA) and Pbin different fractionsin 12 
Pb-contaminated soils. 
Pb bioaccessibility
/RBA 
E1* E1+C2 E1+C2+F3 E1+C2+F3+O4 
slope y-interce
pt 
r2 slope y-intercep
t 
r2 slope y-intercep
t 
r2 slope y-intercep
t 
r2 
UBM GP 2.73 19.4 0.44 1.16 10.3 0.68 0.89 –9.66 0.65 0.72 –10.0 0.52 
IP –0.03 2.45 0.01 0.06 0.29 0.13 0.03 –0.12 0.08 0.03 –0.50 0.08 
SBRC GP 3.59 32.2 0.38 1.87 10.1 0.87 1.29 –17.5 0.75 1.07 –16.6 0.58 
IP 0.60 3.12 0.30 0.28 0.33 0.56 0.21 –4.79 0.55 0.15 –2.60 0.31 
IVG GP 2.76 17.9 0.45 1.28 5.55 0.82 0.92 –15.5 0.76 0.76 –14.1 0.57 
IP 0.68 –1.02 0.67 0.22 –1.01 0.59 0.15 –3.99 0.49 0.11 –2.92 0.31 
PBET GP 2.25 4.85 0.51 0.94 –1.99 0.75 0.66 –16.6 0.67 0.50 –11.5 0.42 
IP 0.24 5.63 0.05 0.27 –0.38 0.52 0.17 –3.57 0.39 0.10 –3.12 0.29 
RBA 2.35 21.8 0.42 0.90 17.3 0.52 0.60 5.76 0.41 0.50 6.04 0.32 
*E1 =exchangeablefraction; C2 =carbonatefraction; F3 =Fe/Mn oxidesfraction; O4 =organicfraction; and R5 =residual fraction. 
r squared> 0.60 was in bold.  
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